Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Revenue Quarterly
0
600K
1.2M
1.8M
Q4 '19: 320.1K
Q1 '20: 293.1K
Q2 '20: 322.5K
Q3 '20: 424.8K
Q4 '20: 172.4K
Q1 '21: 743.9K
Q2 '21: 970.9K
Q3 '21: 1.2M
Q4 '21: 1.4M
Q1 '22: 1.3M
Q2 '22: 1.6M
Q3 '22: 1M
Q4 '22: 799K
Q1 '23: 986.1K
Q2 '23: 699.4K
Q3 '23: 437.9K
Q1 '25: 291.9K
Q2 '25: 196.9K
Q1 '26: 203.7K
Q2 '26: 173.9K
Q1 '20
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q1 '25
Q2 '26
Gross Profit Quarterly
-900K
-600K
-300K
0
300K
600K
900K
Q4 '19: 320.1K
Q1 '20: 293.1K
Q2 '20: 322.5K
Q3 '20: -306.5K
Q4 '20: -591.4K
Q1 '21: -123.2K
Q2 '21: 239.5K
Q3 '21: -238.6K
Q4 '21: -878K
Q1 '22: -223.4K
Q2 '22: -168.5K
Q3 '22: -381.7K
Q4 '22: -539.1K
Q1 '23: -26.5K
Q2 '23: 261.8K
Q3 '23: 78.2K
Q1 '25: 251.9K
Q2 '25: 149.2K
Q1 '26: 202.3K
Q2 '26: 142K
Q1 '20
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q1 '25
Q2 '26
Operating Income Quarterly
-15M
-10M
-5M
0
5M
10M
15M
Q4 '19: -2.5M
Q1 '20: -1.8M
Q2 '20: -3.5M
Q3 '20: -7M
Q4 '20: -3.9M
Q1 '21: -5.9M
Q2 '21: -8.4M
Q3 '21: -6.9M
Q4 '21: -12.1M
Q1 '22: -7M
Q2 '22: -8M
Q3 '22: -6M
Q4 '22: -8.1M
Q1 '23: -13.7M
Q2 '23: -2.7M
Q3 '23: -1.9M
Q1 '25: -2M
Q2 '25: -2.6M
Q1 '26: -12.3M
Q2 '26: -2.3M
Q1 '20
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q1 '25
Q2 '26
Net Income Quarterly
-18M
-12M
-6M
0
6M
12M
18M
Q4 '19: -2.6M
Q1 '20: -3M
Q2 '20: -4.1M
Q3 '20: -16.2M
Q4 '20: -906.1K
Q1 '21: -6.6M
Q2 '21: -8.6M
Q3 '21: -9.8M
Q4 '21: -12.3M
Q1 '22: -6.3M
Q2 '22: -8.3M
Q3 '22: -9.2M
Q4 '22: -8.5M
Q1 '23: -15.9M
Q2 '23: -4.5M
Q3 '23: -2.9M
Q1 '25: -2M
Q2 '25: -1.3M
Q1 '26: -14.4M
Q2 '26: -2.5M
Q1 '20
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q1 '25
Q2 '26
Cost of Revenue Quarterly
0
700K
1.4M
2.1M
Q2 '15: 109.4K
Q3 '15: 38.8K
Q1 '16: 34.4K
Q2 '16: 8.9K
Q3 '16: 0
Q4 '16: 0
Q3 '20: 731.3K
Q1 '21: 867.1K
Q2 '21: 731.3K
Q3 '21: 1.4M
Q4 '21: 1.1M
Q1 '22: 1.6M
Q2 '22: 1.8M
Q3 '22: 1.4M
Q4 '22: 1.3M
Q1 '23: 1M
Q2 '23: 437.6K
Q3 '23: 359.7K
Q2 '25: 47.8K
Q2 '26: 32K
Q3 '15
Q3 '16
Q1 '21
Q4 '21
Q3 '22
Q2 '23
Q2 '26
Operating Cash Flow Quarterly
-6M
-4M
-2M
0
2M
4M
6M
Q4 '19: -1.2M
Q1 '20: -1.3M
Q2 '20: -1.6M
Q3 '20: -2.1M
Q4 '20: -2.3M
Q1 '21: -5.3M
Q2 '21: -5.7M
Q3 '21: -4.6M
Q4 '21: -4.9M
Q1 '22: -5M
Q2 '22: -5.6M
Q3 '22: -3.2M
Q4 '22: -2.9M
Q1 '23: -2.9M
Q2 '23: -332.5K
Q3 '23: -193.7K
Q1 '25: -710.5K
Q2 '25: 31.7K
Q1 '26: -1.3M
Q2 '26: -1.1M
Q1 '20
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q1 '25
Q2 '26
Free Cash Flow Quarterly
-6M
-4M
-2M
0
2M
4M
6M
Q3 '16: -587K
Q4 '16: -588.9K
Q3 '18: -1.1M
Q4 '18: -1.5M
Q1 '19: -1.5M
Q2 '19: -1.7M
Q3 '19: -1.6M
Q4 '19: -1.2M
Q3 '20: -2.2M
Q4 '20: -2.3M
Q1 '21: -5.3M
Q2 '21: -5.7M
Q3 '21: -4.7M
Q4 '21: -4.9M
Q1 '22: -5.1M
Q2 '22: -5.7M
Q3 '22: -3.3M
Q4 '22: -2.9M
Q1 '26: -1.3M
Q2 '26: -1.2M
Q4 '16
Q1 '19
Q4 '19
Q1 '21
Q4 '21
Q3 '22
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
50M
100M
150M
Q2 '10: 2.6M
Q3 '10: 2.6M
Q2 '11: 2.6M
Q3 '11: 2.6M
Q1 '21: 9.8M
Q2 '21: 11.1M
Q3 '21: 13.7M
Q1 '22: 17.7M
Q2 '22: 20.2M
Q3 '22: 21M
Q1 '23: 63.5M
Q2 '23: 91.2M
Q3 '23: 120.3M
Q2 '10
Q2 '11
Q1 '21
Q3 '21
Q2 '22
Q1 '23
Q3 '23
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-7.50
-5.00
-2.50
0.00
2.50
5.00
7.50
Q3 '18: -3.00
Q4 '18: -3.00
Q1 '19: -3.23
Q2 '19: -2.21
Q3 '19: -1.19
Q4 '19: -2.01
Q1 '20: -2.69
Q2 '20: -3.79
Q3 '20: -6.95
Q4 '20: -5.68
Q1 '21: -5.40
Q2 '21: -4.91
Q3 '21: -1.81
Q4 '21: -3.44
Q1 '22: -3.12
Q2 '22: -2.72
Q3 '22: -2.46
Q4 '22: -1.59
Q1 '23: -1.58
Q2 '23: -1.29
Q4 '18
Q3 '19
Q2 '20
Q1 '21
Q4 '21
Q3 '22
Q2 '23
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.